U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants - 10/25/2024
  1. News & Events

Meeting | In Person

Event Title
Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants
October 25, 2024

Date:
October 25, 2024
Time:
9:00 AM - 4:00 PM ET

Register by October 15, 2024, 11:59pm.

Location:
NIH, National Institute of Allergy and Infectious Diseases Building
Conference Center, Grand Hall
5601 Fishers Lane
Rockville, MD  20892

The Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH), the National Institute of Allergy and Infectious Diseases (NIAID), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (collectively, we) are announcing a public workshop entitled “Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants.” The purpose of the public workshop is to exchange information with the medical and scientific community about the regulatory and scientific issues associated with use of live biotherapeutic products to prevent necrotizing enterocolitis (NEC) in very low birth weight (VLBW) infants.

See meeting Federal Register Notice for further information regarding submitting comments to the docket. The deadline for submitting comments is November 25, 2024, at 11:59pm Easter Time.

Back to Top